The value of ATAD3A as a potential biomarker for bladder cancer.

Zhenghong LiuLi SunBin ZhengHeng WangXiaowen QinPu ZhangQijun WoHaichang LiYixuan MouDahong ZhangShuai Wang

Published in: Cancer medicine (2023)

The abnormal overexpression of ATAD3A may be related to the initiation and progress of bladder cancer. The upregulation of ATAD3A can be used as an effective indicator to diagnose bladder cancer and predict tumor progression. Furthermore, the combination of information from public databases and the results of clinical sample analysis can help us better understand the mechanism of action of molecular oncogenes in bladder cancer.

Keyphrases

poor prognosis
cell proliferation
healthcare
mental health
signaling pathway
muscle invasive bladder cancer
machine learning
social media
health information
electronic health record